COMBINATIONS OF PER ORAL MEDICATIONS, CONNECTED BY COATING Russian patent published in 2013 - IPC A61K9/48 A61K9/30 A61J3/07 A61J3/10 

Abstract RU 2493832 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: per oral pharmaceutical drug form, in composition of which included are at least two medical substances in from of separately preliminarily formed pills. In claimed form medicinal substances from one side are together in hermetically in vivo water-soluble wrapping or coating, and from the other side are separated in such a way, that active agents of combined medicinal substances cannot contact with each other. At least one of medications is selected from the following groups of therapeutic medications: non-steroidal anti-inflammatory preparation (NAIP), inhibitor of proton pump (IPP), beta-blocker, statin, conversion enzyme inhibitor (CEI), biguanide, neuromuscular blocking agent, calcium inhibitor, corticoid, antidepressant, benzodiazepine, inhibitor of intestinal transit of non-atropine-like action, intestinal antibacterial medication, and following therapeutic molecules: spironolactone, propranolol, clarithromycin, amoxicillin, low dose acetylsalicylic acid, potassium, clopidogrel.

EFFECT: pharmaceutical drug form by invention ensures patient with one drug form for several medicinal preparations, which makes it possible to avoid separate introduction of medicinal preparations.

21 cl, 7 dwg

Similar patents RU2493832C2

Title Year Author Number
PHARMACEUTICAL COMPOSITION CONTAINING BETA-BLOCKER, CONVERTING ENZYME INHIBITOR AND HYPOTENSIVE AGENT OR NSAID 2017
  • Fonknekhten Zhil
RU2756320C2
PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND ACE INHIBITOR 2016
  • Fonknekhten Zhil
RU2750934C2
COMPOSITION INHIBITING SECRETION OF ACID IN STOMACH 2003
  • Pettersson Anders
  • Njustrem Krister
  • Khokansson Ivonne
RU2340358C2
CONTROLLED RELEASE COMPLEX PHARMACEUTICAL COMPOSITION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKERS AND HYDROXIMETHYLGLUTARYL-COA REDUCTASE INHIBITORS 2007
  • Kim Sun"Uk
  • Chun Sunsu
  • Cho Jungvan
  • Ku Chason
  • Son Chehun
RU2453307C2
COMBINED CONTROLLED-RELEASE PHARMACEUTICAL AGENT CONTAINING DIHYDROPYRIDINE CALCIUM CANAL BLOCKERS AND HMG-CoA-REDUCTASE INHIBITORS 2007
  • Kim Sung Vuk
  • Dzun Sung Soo
  • Dzo Joung Gvan
  • Koo Dza-Seong
  • Kim Dzin Vook
RU2450804C2
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES 2011
  • Germanov Sergej Borisovich
  • Gomzhin Andrej Mikhajlovich
  • Timko Vladimir Grigor'Evich
RU2491070C2
CHRONOTHERAPEUTIC PHARMACEUTICAL COMPOSITION 2010
  • Boldkhane Sandzhaj
  • Jatkhar Skhripad
  • Nerurkar Manish
RU2571067C2
COMPOSITION AND METHOD FOR PRODUCING A SOLID DOSAGE FORM CONTAINING (Z)-3-(2-OXO-2-(4-TOLYL)ETHYLIDENE)PIPERAZIN-2-ONE 2017
  • Mashevskaya Irina Vladimirovna
  • Kotegov Viktor Petrovich
  • Makhmudov Ramiz Ragibovich
  • Suldin Aleksandr Sergeevich
  • Puchnina Svetlana Vladimirovna
RU2657526C1
PERORAL COMPOSITION WITH PROLONGED MOLSIDOMINE RELEASE FOR ATHEROSCLEROSIS TREATMENT 2005
  • Gezhi Jozef-Mishel'
RU2388475C2
METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION CONTAINING A NON-STEROIDAL ANTI-INFLAMMATORY DRUG, A PROTON PUMP INHIBITOR AND AN ANTACID, A PHARMACEUTICAL COMPOSITION CONTAINING A NON-STEROIDAL ANTI-INFLAMMATORY DRUG, A PROTON PUMP INHIBITOR AND AN ANTACID, THE USE OF A PHARMACEUTICAL COMPOSITION 2021
  • Shestakov Vladislav Nikolaevich
  • Polyakov Sergej Viktorovich
  • Persanova Lyudmila Vasilevna
  • Ulyanov Andrej Mikhajlovich
  • Skupchenko Viktoriya Viktorovna
  • Veretennikova Mariya Aleksandrovna
  • Mamedova Dzheneta Alievna
  • Morozov Andrej Vladimirovich
  • Ajrapetyan Kristine Aleksanovna
  • Mirov Andrej Vladimirovich
  • Miranyan Kishmish Artashovna
  • Amandusova Akzhvek Khasanovna
RU2790691C1

RU 2 493 832 C2

Authors

Ljugrehn Ann-Ehmmanjuehll'

Griselli Klod

Ehl' Glaui Medi

Ehl' Glaui Gijom

Offel' Zhan

Dates

2013-09-27Published

2009-01-26Filed